Danish biotechnology startup Visibuilt has raised €3.34 million in seed funding in a round co-led by EIFO and Unconventional Ventures, with participation from Proptechfonden and follow-on backing from existing investor EMDFonden. The company develops visiBINDER, a mycelium-based binder designed to replace carbon-intensive materials such as bitumen and cement in paving and infrastructure applications. The fresh capital will be used to scale the technology beyond laboratory pilots by expanding validation and testing, establishing production capabilities for larger-scale trials, strengthening the technical and commercial team, and preparing the platform for commercial market deployment with industry partners. Visibuilt develops biobased...
Les hele artikkelen hos kilden.
Kommentarer (0)
Ingen kommentarer ennå. Bli den første til å kommentere!